Related Experiment Video
Updated: Nov 26, 2025

10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
7.5K
Meningococcal Vaccines: Challenges and Prospects
Priyal Bagwe1, Lotika Bajaj1, Rikhav Gala2
1Center for Drug Delivery Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Vaccines
|December 9, 2020
Abstract:
Neisseria meningitidis is a gram-negative bacterium that causes a severe acute infection, called the meningococcal disease [...].
Insights
Neisseria meningitidis causes severe meningococcal disease. This research explores the bacterium
Area of Science:
- Microbiology and infectious diseases.
- Bacteriology and pathogen research.
Background:
- Neisseria meningitidis is a gram-negative bacterium responsible for meningococcal disease.
- Meningococcal disease presents as a severe acute infection.
Discussion:
- Further investigation into Neisseria meningitidis pathogenesis is crucial.
- Understanding the bacterium's mechanisms is key to combating meningococcal disease.
Key Insights:
- Neisseria meningitidis is a significant public health concern.
- The bacterium's role in severe infections warrants detailed study.
Outlook:
- Future research should focus on novel therapeutic strategies.
- Developing effective interventions against Neisseria meningitidis is a priority.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
685
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
685
Vaccinations
49.5K
Overview
49.5K

